no statement of use filed
on 11 Apr 2022
Last Applicant/ Owned by
215 First Street
Cambridge
MA
02142
Serial Number
88886703 filed on 24th Apr 2020
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, geneticRead More
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
No 88886703
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
11th Apr 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
11th Apr 2022 | ABANDONMENT - NO USE STATEMENT FILED |
28th Aug 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
26th Aug 2021 | EXTENSION 2 GRANTED |
26th Aug 2021 | EXTENSION 2 FILED |
26th Aug 2021 | TEAS EXTENSION RECEIVED |
23rd Feb 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
19th Feb 2021 | EXTENSION 1 GRANTED |
19th Feb 2021 | EXTENSION 1 FILED |
19th Feb 2021 | TEAS EXTENSION RECEIVED |